Premarket Stock Movements: Replimune Surges Over 130%, Amazon Rises More Than 11%
Replimune Group's shares surged over 130% premarket after the FDA advisory panel supported its RP1 drug trial results for a skin cancer treatment. Wedbush Securities upgraded Replimune to 'outperform' following this development. Chevron saw slight gains as it reported better-than-expected Q2 earnings and revenue, with net income reaching $12.1 billion—a nearly 400% increase year-over-year. In contrast, ExxonMobil shares fell after reporting weaker-than-anticipated results. Amazon's stock jumped over 11%, driven by stronger cloud growth than expected. Apple’s shares dropped more than 7% despite beating revenue forecasts due to strong iPhone sales. Coinbase and Reddit also saw declines in share prices amid disappointing financial reports or guidance.
Tickers: $AAPL $AMZN $COIN $CVX $MRNA $REPL $XOM
Topics: earnings reports FDA approval IPO performance stock market